Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/29348
Title: Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension
Authors: Koklin, I. S.
Danilenko, L. M.
Keywords: medicine
pharmacology
monocrotaline
pulmonary hypertension
arginase II inhibitors
tadalafil
Issue Date: 2019
Citation: Koklin, I.S. Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension / I.S. Koklin, L.M. Danilenko // Research Results in Pharmacology. - 2019. - Vol.5, №3.-P. 79-85. - Doi: 10.3897/rrpharmacology.5.39522. - Refer.: p. 84.
Abstract: The concept of the regulatory role of endothelium in the pathogenesis of pulmonary hypertension (PH) is fundamental. To study the protective effects of the selective arginase II inhibitors L207-0525 and L327-0346 in combination with tadalafil in a monocrotaline model of pulmonary hypertension in rats
URI: http://dspace.bsu.edu.ru/handle/123456789/29348
Appears in Collections:Research Result. Pharmacology and Clinical Pharmacology

Files in This Item:
File Description SizeFormat 
Koklin_Combined.pdf1.47 MBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.